- €322.53m
- €227.09m
- €785.00m
- 81
- 55
- 63
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 706 | 579 | 742 | 822 | 785 |
Cost of Revenue | |||||
Gross Profit | 419 | 334 | 430 | 490 | 456 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 676 | 573 | 696 | 772 | 761 |
Operating Profit | 29.6 | 6.22 | 45.7 | 50.7 | 24.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 23.4 | 3.22 | 40.5 | 41.6 | 20.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 13 | 2.46 | 34.2 | 30.3 | 12.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 13 | 2.53 | 34 | 30.2 | 12.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 13 | 2.53 | 34 | 30.2 | 12.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.573 | 0.299 | 0.778 | 1.07 | 0.457 |
Dividends per Share |